97精品国产自-97精品国产自产-97精品国产综合久久-97精品久-97精品免费视频-97精品人人

廚房設備網
手機版
首頁> 資訊>政策法規> 正文

(EU) No 2015/1492:就乙酰異戊酰泰樂菌素,修訂法規(EU) No 37/2010附錄

發布時間:2017-05-02 09:35:41   發布人: 互聯網    點擊數:566  

COMMISSION IMPLEMENTING REGULATION (EU) 2015/1492     of 3 September 2015     amending Regulation (EU) No 37/2010 as regards the substance ‘tylvalosin’     (Text with EEA relevance)     THE EUROPEAN COMMISSION,     Having regard to the Treaty on the Functioning of the European Union,     Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (1), and in particular Article 14 in conjunction with Article 17 thereof,     Having regard to the opinion of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,     Whereas:     (1)     Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (hereinafter ‘MRL’) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is established in a regulation.     (2)     Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.     (3)     Tylvalosin is currently included in that table as an allowed substance, for porcine and poultry species, applicable to muscle, skin and fat, liver and kidney in porcine species and to skin and fat and liver in poultry species, excluding animals producing eggs for human consumption.     (4)     An application for the extension of the existing entry for tylvalosin to chicken eggs has been submitted to the European Medicines Agency (hereinafter ‘EMA’).     (5)     The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use has recommended the establishment of a MRL for chicken eggs.     (6)     According to Article 5 of Regulation (EC) No 470/2009 the EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.     (7)     The EMA has considered that the extrapolation of the MRLs for tylvalosin from chicken eggs to eggs of other poultry species is appropriate.     (8)     Regulation (EU) No 37/2010 should therefore be amended accordingly.     (9)     It is appropriate to grant the stakeholders concerned a reasonable period of time to take measures that may be required to comply with the new MRL.     (10)     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,     HAS ADOPTED THIS REGULATION:     Article 1     The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.     Article 2     This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.     It shall apply from 3 November 2015.     This Regulation shall be binding in its entirety and directly applicable in all Member States.     Done at Brussels, 3 September 2015.     For the Commission     The President     Jean-Claude JUNCKER     (1)  OJ L 152, 16.6.2009, p. 11.     (2)  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).     ANNEX     In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘tylvalosin‘ is replaced by the following:
   

harmacologically active substance

Marker residue

Animal species

MRL

Target tissues

Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic classification

‘Tylvalosin

Tylvalosin

orcine

50 μg/kg

50 μg/kg

50 μg/kg

50 μg/kg

Muscle

kin and fat

Liver

Kidney

O ENTRY

Anti-infectious agents/Antibiotics’

oultry

200 μg/kg

Eggs

um of Tylvalosin and 3-0-acetyltylosin

oultry

50 μg/kg

50 μg/kg

kin and fat

Liver

免責聲明:本網站所收集的部分公開資料來源于互聯網,轉載的目的在于傳遞更多信息及用于網絡分享,并不代表本站贊同其觀點和對 其真實性負責,也不構成任何其他建議。如果您發現網站上有侵犯您的知識產權的作品,請與我們取得聯系,我們會及時修改或刪除。

同類資訊

推薦資訊 更多
點擊排行

版權所有:廚聯科技 (c)2008-2022 CFSBCN All Rights Reserved

客戶服務郵箱:350319542@cfsbcn.com 郵編:610000 蜀ICP備14006818號-4 聯系電話:13880215230

成都地址:成都高新區府城大道西段399天府新谷10號樓17F

主站蜘蛛池模板: 波多野结衣与老人中出 | 国产午夜毛片v一区二区三区 | 美国毛片免费一级久久99国产精品一区二区 | 日本中文字幕在线视频一区 | a级国产乱理伦片 | 国产蜜桃tv一区二区无码 | 国产乱子经典视 | 久久久久久久久蜜桃 | 人妻无码久久久久久久久久久 | 国产成人无码精品午夜福利a | 国产精品亚洲综合五月天 | 91丝袜高潮 | 免费又黄又爽1000禁片 | 无码中文字幕免费一区二区三区 | 成人爱做日本视频免费 | 国产精品午夜无码AV在线播放 | 成人综合国产精品 | 国产高颜值露脸在 | 免费做爰猛烈吃奶摸视频在线观看 | 91免费公开视频 | 国产精品国产三级国产普通话对白 | 日日碰狠狠躁久久躁综合网 | 精品国产成人 | 久久久免费看少妇高潮A片特黄 | 国产成人欧美一区二区三区vr | 久久久久无码国产精品一区 | 中文字幕国产在线观看 | 久久久久毛片成人精品 | 国产午夜精品自在自线之la | 性感美女视频在线观看一区二区 | 久久精品久久久久久国产越南 | 无码人妻一区二区三区野外 | 国产另类ts人 | 91系列高清露脸对白 | 无码免费人妻A片AAA毛片 | 亚洲欧洲日本天天堂在线观看 | 国产成人片无码免费 | 91精品啪在线观看国产91九色 | 国产女人与拘的交酡 | 久热久热 | 国产免费无码又爽又刺激A片动漫 |